Indoor Harvest Acquires Majority Control In Metabiogenix USA


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


Indoor Harvest Corp. (OTCPK:INQD) announced the acquisition of a 60% controlling interest in Metabiogenix USA for $2.5 million in a combination of cash and common stock. During the close of the acquisition, Metabiogenix USA received a valuation of $8.9 million from the Japanese Medical Institute.

“This acquisition will provide Indoor Harvest an exclusive agreement to market and distribute the portfolio of Metabiogenix USA Nutraceuticals throughout the entire Western Hemisphere (North, South, and Central America), and Spain. Metabiogenix USA is on track for substantial growth and projecting revenues that could be as high as $20 million for FY2024” stated Leslie Bocskor, chairman & CEO of INQD. “Words cannot express the gratitude I am experiencing to have Dr. Mario Acosta Mejia join Indoor Harvest and look forward to working with him to develop this paradigm shifting class of health and wellness products as he continues to lead Metabiogenix USA.”

With the evolution of wellness and health technologies built from the foundation of probiotics, a new generation of metabiotics has been developed by the Japanese Medical Institute to work towards improving the life expectancy and quality of life to people around the world. Japan currently has the longest life expectancy with the average lifespan of 87 years. Dr. Acosta, co-founder and president of Metabiogenix USA, was among the original principal clinical investigators at the Japanese Medical Institute and was instrumental in developing Metabiox.

“After years of working with my counterparts in Japan, Mexico, and Europe to develop this new class of health and wellness products, we will continue to revolutionize preventative methods around the world by bringing education and tools to doctors and medical practitioners as these patented products continue to evolve,” stated Dr. Acosta. “I am honored to join the Indoor Harvest family and looking forward to leading Metabiogenix USA and educating the world about “The Metabolism of Life!”.

As part of the acquisition, Dr. Acosta will be retained under a new developing employment agreement as president of Metabiogenix USA.

Photo: Benzinga edit with photos by jarmoluk and lindsayfox on Pixabay

Related News

Indoor Harvest Corp. Acquires 369Hemp, Plans To Expand Into Smokable Hemp Market


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: CannabisNewsMarketsJapanese Medical InstituteLeslie BocskorMario Acosta MejiaMetabiogenix USApremium